Page 126 - 《中国药房》2023年18期

ting stem cell signaling pathways in triple-negative breast [30] DUAN Z F，AMES R Y，RYAN M，et al. CDDO-Me，a
cancer[J]. PLoS One，2014，9（9）：e107616. synthetic triterpenoid，inhibits expression of IL-6 and
[18] ROGERS L J，JOHN T，PARK J，et al. Growth inhibition Stat3 phosphorylation in multi-drug resistant ovarian can‐
and apoptosis of human multiple myeloma cells induced cer cells[J]. Cancer Chemother Pharmacol，2009，63（4）：
by 2-cyano-3，12-dioxooleana-1，9-dien-28-oic acid 681-689.
derivatives[J]. Anticancer Drugs，2020，31（8）：806-818. [31] GEE M S，KANG S B，KIM N，et al. Bardoxolone methyl
[19] TSAI T H，LIEU A S，HUANG T Y，et al. Induction of suppresses hepatitis B virus large surface protein variant
mitosis delay and apoptosis by CDDO-TFEA in gliobla- W4P-related carcinogenesis and hepatocellular carcinoma
stoma multiforme[J]. Front Pharmacol，2021，12：756228. cell proliferation via the inhibition of signal transducer
[20] ALABRAN J L，CHEUK A，LIBY K，et al. Human neuro‐ and activator of transcription 3 signaling[J]. Pharmaco-
blastoma cells rapidly enter cell cycle arrest and apoptosis logy，2018，102（1/2）：105-113.
following exposure to C-28 derivatives of the synthetic [32] 罗欢，何兰，何迎春，等 . 核因子-κB（NF-κB）与核因子
triterpenoid CDDO[J]. Cancer Biol Ther，2008，7（5）： E2 相关因子 2（Nrf2）信号通路交互对结直肠癌防治及
709-717. 中药研究的启示[J]. 中国临床药理学杂志，2021，37
[21] WANG Y Y，YANG Y X，ZHAO R，et al. Bardoxolone （10）：1266-1271，1276.
methyl induces apoptosis and autophagy and inhibits [33] KHURANA N，CHANDRA P K，KIM H，et al. Bardoxolone-
epithelial-to-mesenchymal transition and stemness in methyl（CDDO-Me）suppresses androgen receptor and its
esophageal squamous cancer cells[J]. Drug Des Devel splice-variant AR-V7 and enhances efficacy of enzaluta‐
Ther，2015，9：993-1026. mide in prostate cancer cells[J]. Antioxidants（Basel），
[22] CASARES L，MORENO R，ALI K X，et al. The synthetic 2020，9（1）：68.
triterpenoids CDDO-TFEA and CDDO-Me，but not [34] MOERLAND J A，LEAL A S，LOCKWOOD B，et al. The
CDDO，promote nuclear exclusion of BACH1 impairing triterpenoid CDDO-methyl ester redirects macrophage
its activity[J]. Redox Biol，2022，51：102291. polarization and reduces lung tumor burden in a Nrf2-
[23] JANG H Y，HONG O Y，YOUN H J，et al. CDDO，a dependent manner[J]. Antioxidants（Basel），2023，12
PPAR- γ ligand，inhibits TPA-induced cell migration and （1）：116.
invasion through a PPAR- γ -independent mechanism[J]. [35] DEEB D，GAO X H，JIANG H，et al. Oleanane triterpe‐
Oncol Lett，2022，24（4）：354. noid CDDO-Me inhibits growth and induces apoptosis in
[24] SOARES I N，VIANA R，TRELFORD C B，et al. The syn‐ prostate cancer cells by independently targeting pro-survival
thetic oleanane triterpenoid CDDO-Me binds and inhibits Akt and mTOR[J]. Prostate，2009，69（8）：851-860.
pyruvate kinase M2[J]. Pharmacol Rep，2020，72（3）： [36] ZHOU L，WANG Z Y，YU S B，et al. CDDO-Me elicits
631-640. anti-breast cancer activity by targeting LRP6 and FZD7
[25] AKUETTEH P D P，HUANG H M，WU S J，et al. Syn‐ receptor complex[J]. J Pharmacol Exp Ther，2020，373
thetic oleanane triterpenoid derivative CDDO-Me disrupts （1）：149-159.
cellular bioenergetics to suppress pancreatic ductal adeno‐ [37] SHISHODIA S，SETHI G，KONOPLEVA M，et al. A
carcinoma via targeting SLC1A5[J]. J Biochem Mol Toxi‐ synthetic triterpenoid，CDDO-Me，inhibits IkappaBalpha
col，2022，36（11）：e23192. kinase and enhances apoptosis induced by TNF and
[26] ZHAO Y，HUO M R，XU Z H，et al. Nanoparticle deli- chemotherapeutic agents through down-regulation of
very of CDDO-Me remodels the tumor microenvironment expression of nuclear factor kappaB-regulated gene products
and enhances vaccine therapy for melanoma[J]. Biomate- in human leukemic cells[J]. Clin Cancer Res，2006，12
rials，2015，68：54-66. （6）：1828-1838.
[27] BALL M S，BHANDARI R，TORRES G M，et al. CDDO- [38] STADHEIM T A，SUH N，GANJU N，et al. The novel
Me alters the tumor microenvironment in estrogen recep‐ tri-terpenoid 2-cyano-3，12-dioxooleana-1，9-dien-28-oic
tor negative breast cancer[J]. Sci Rep，2020，10（1）：656. acid（CDDO）potently enhances apoptosis induced by
[28] 洪梓德，莫志贤 . 中药抗肿瘤机制中的 11 种信号通路 tumor necrosis factor in human leukemia cells[J]. J Biol
[J]. 中国实验方剂学杂志，2018，24（21）：205-218. Chem，2002，277（19）：16448-16455.
[29] JOHNSON D E，O’KEEFE R A，GRANDIS J R. Targe- （收稿日期：2023-04-03 修回日期：2023-08-15）
ting the IL-6/JAK/STAT3 signalling axis in cancer[J]. Nat （编辑：邹丽娟）
Rev Clin Oncol，2018，15（4）：234-248.

· 2292 · China Pharmacy 2023 Vol. 34 No. 18 中国药房 2023年第34卷第18期